Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species

Biochemical Journal

Volumn 389, Issue 1, 2005, Pages 151-159

  Vangheluwe, Peter ^a   Schuermans, Marleen ^a   Zádor, Ernö ^b   Waelkens, Etienne ^a   Raeymaekers, Luc ^a   Wuytack, Frank ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Atrium; Cardiomyopathy; Phospholamban; Sarcolipin; Sarcoplasmic endoplasmic reticulum Ca2+ ATPase (SERCA); Skeletal muscle

Indexed keywords

CELLS; ENZYME INHIBITION; RNA;

ENDOPLASMIC RETICULUM; PHOSPHOLAMBAN (PLB); PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM;

PROTEINS;

MEMBRANE PROTEIN; PHOSPHOLAMBAN; SARCOLIPIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTENSOR DIGITORUM LONGUS MUSCLE; HEART ATRIUM; HEART MUSCLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RABBIT; RAT; SKELETAL MUSCLE; SPECIES DIFFERENCE; SWINE; UPREGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; PROTEOLIPIDS; RABBITS; RATS; RATS, WISTAR; REFERENCE STANDARDS; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SPECIES SPECIFICITY; SWINE;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA; SUS SCROFA;

EID: 22144491856     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20050068     Document Type: Article

References (23)

1. MacLennan, D. H.,Asahi, M. and Tupling, A. R. (2003) The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann. N.Y. Acad. Sci. 986, 472-480
2. 2+-ATPases (SERCAs). J. Biol. Chem. 277, 26725-26728
3. 2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc. Natl. Acad. Sci. U.S.A. 100, 5040-5045
4. 2+-ATPaSe. J. Biol. Chem. 273, 12360-12369
5. Minamisawa, S., Wang, Y., Chen, J., Ishikawa, Y., Chien, K. R. and Matsuoka, R. (2003) Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J. Biol. Chem. 278, 9570-9575
6. Odermatt, A., Taschner, P. E., Scherer, S. W., Beatty, B., Khanna, V. K., Cornblath, D. R., Chaudhry, V., Yee, W. C., Schrank, B., Karpati, G. et al. (1997) Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 45, 541-553
7. Babu, G. J., Zheng, Z., Natarajan, P., Wheeler, D., Janssen, P. M. and Periasamy, M. (2005) Overexpression of sarcolipin decreases myocyte contractility and calcium transient. Cardiovasc. Res. 65, 177-186
8. Uemura, N., Ohkusa, T., Hamano, K., Nakagome, M., Hori, H., Shimizu, M., Matsuzaki, M., Mochizuki, S., Minamisawa, S. and Ishikawa, Y. (2004) Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation. Eur. J. Clin. Invest. 34, 723-730
9. 2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ. Res. 89, 838-846
10. Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B. et al. (2004) PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248-254
11. 2+ transport genes in platelets and endothelial cells in hypertension. Hypertension 37, 135-141
12. Ohnoki, S. and Martonosi, A. (1980) Purification and characterization of the proteolipid of rabbit sarcoplasmic reticulum. Biochim. Biophys. Acta 626, 170-178
13. Luss, I., Boknik, P., Jones, L. R., Kirchhefer, U., Knapp, J., Linck, B., Luss, H., Meissner, A., Muller, F. U., Schmitz, W. et al. (1999) Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species. J. Mol. Cell. Cardiol. 31, 1299-1314
14. Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T. and Kranias, E. G. (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ. Res. 75, 401-409
15. 2+ uptake and impairs contractile function. J. Biol. Chem. 277, 44740-44746
16. Slack, J. P., Grupp, I. L., Luo, W. and Kranias, E. G. (1997) Phospholamban ablation enhances relaxation in the murine soleus. Am. J. Physiol. 273, C1-C6
17. Gayan-Ramirez, G., Vanzeir, L., Wuytack, F. and Decramer, M. (2000) Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm. J. Physiol. 524, 387-397
18. 2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 9199-9204
19. Koss, K. L., Ponniah, S., Jones, W. K., Grupp, I. L. and Kranias, E. G. (1995) Differential phospholamban gene expression in murine cardiac compartments: molecular and physiological analyses. Circ. Res. 77, 342-353
20. Minajeva, A., Kaasik, A., Paju, K., Seppet, E., Lompre, A. M., Veksler, V. and Ventura-Clapier, R. (1997) Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart. Am. J. Physiol. 273, H2498-H2507
21. Freestone, N. S., Ribaric, S., Scheuermann, M., Mauser, U., Paul, M. and Vetter, R. (2000) Differential lusitropic responsiveness to β-adrenergic stimulation in rat atrial and ventricular cardiac myocytes. Pflugers Arch. 441, 78-87
22. Kaasik, A., Paju, K., Minajeva, A. and Ohisalo, J. (2001) Decreased expression of phospholamban is not associated with lower β-adrenergic activation in rat atria. Mol. Cell. Biochem. 223, 109-115
23. Miller, L. D., McPhie, P., Suzuki, H., Kato, Y., Liu, E. T. and Cheng, S. Y. (2004) Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol. 5, R31